HK1099228A1 - Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis - Google Patents

Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis

Info

Publication number
HK1099228A1
HK1099228A1 HK07106587.9A HK07106587A HK1099228A1 HK 1099228 A1 HK1099228 A1 HK 1099228A1 HK 07106587 A HK07106587 A HK 07106587A HK 1099228 A1 HK1099228 A1 HK 1099228A1
Authority
HK
Hong Kong
Prior art keywords
adefovir
tenofovir
breast cancer
mmtv
biliary cirrhosis
Prior art date
Application number
HK07106587.9A
Other languages
English (en)
Inventor
Cihlar Tomas
Janet L Douglas
Craig S Gibbs
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of HK1099228A1 publication Critical patent/HK1099228A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK07106587.9A 2004-01-21 2007-06-20 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis HK1099228A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53806604P 2004-01-21 2004-01-21
PCT/US2005/002043 WO2005072748A1 (en) 2004-01-21 2005-01-21 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis

Publications (1)

Publication Number Publication Date
HK1099228A1 true HK1099228A1 (en) 2007-08-10

Family

ID=34825960

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07106587.9A HK1099228A1 (en) 2004-01-21 2007-06-20 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis

Country Status (11)

Country Link
US (2) US20050239753A1 (nl)
EP (1) EP1732569B1 (nl)
JP (1) JP2007518815A (nl)
AT (1) ATE445404T1 (nl)
AU (1) AU2005209256B2 (nl)
CA (1) CA2553455A1 (nl)
DE (1) DE602005017131D1 (nl)
ES (1) ES2334149T3 (nl)
HK (1) HK1099228A1 (nl)
NZ (1) NZ548532A (nl)
WO (1) WO2005072748A1 (nl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006114064A2 (en) * 2005-04-25 2006-11-02 Institute Of Organic Chemistry And Biochemistry Ofthe Academy Of Sciences Of The Czech Republic Use of compounds to enhance processivity of telomerase
CN101442994B (zh) 2006-05-16 2013-03-06 吉里德科学公司 用于治疗恶性血液病的方法和组合物
AU2010303628B2 (en) * 2009-10-05 2015-07-09 Ambergen, Inc. A method for diagnosing primary biliary cirrhosis (PBC) using novel autoantigens
WO2012048113A2 (en) 2010-10-07 2012-04-12 The General Hospital Corporation Biomarkers of cancer
US9089574B2 (en) 2011-11-30 2015-07-28 Emory University Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
ES2892123T3 (es) 2014-12-26 2022-02-02 Univ Emory Derivados antivíricos de N4-hidroxicitidina
GB201509431D0 (en) * 2015-06-01 2015-07-15 Equigerminal Sa Antiviral composition
GB2581936B (en) 2017-12-07 2021-02-10 Univ Emory N4-hydroxycytidine and derivatives and anti-viral uses related thereto
KR102196711B1 (ko) * 2018-08-30 2020-12-30 가톨릭대학교 산학협력단 테노포비르 디소프록실 푸마르산을 유효성분으로 함유하는, 간섬유증 예방 또는 치료용 약학적 조성물
WO2020171225A1 (ja) * 2019-02-22 2020-08-27 一素 村田 ｍＴＯＲ阻害剤
US12016844B2 (en) 2019-07-02 2024-06-25 Virago Vax Inc. Mammary tumor virus suppression
EP3993873A4 (en) * 2019-07-02 2023-09-20 Virago Vax Inc. SUPPRESSION OF BREAST TUMORS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003512023A (ja) * 1999-06-01 2003-04-02 アルトン オケスナー メディカル ファウンデーション 原発性胆汁性肝硬変および自己免疫障害に関連する新規レトロウイルスの同定
DK1190055T3 (da) * 1999-06-30 2008-09-22 Univ Tulane Human endogen retrovirus
JP4651264B2 (ja) * 2000-07-21 2011-03-16 ギリアード サイエンシーズ， インコーポレイテッド ホスホネートヌクレオチドアナログのプロドラッグならびにこれを選択および作製するための方法。
JP4476811B2 (ja) * 2002-05-13 2010-06-09 メタバシス・セラピューティクス・インコーポレイテッド Ｐｍｅａおよびそのアナログの新規ホスホン酸系プロドラッグ

Also Published As

Publication number Publication date
JP2007518815A (ja) 2007-07-12
WO2005072748A1 (en) 2005-08-11
CA2553455A1 (en) 2005-08-11
EP1732569B1 (en) 2009-10-14
US20070281911A1 (en) 2007-12-06
EP1732569A1 (en) 2006-12-20
AU2005209256B2 (en) 2010-11-18
ATE445404T1 (de) 2009-10-15
NZ548532A (en) 2009-09-25
US20050239753A1 (en) 2005-10-27
DE602005017131D1 (de) 2009-11-26
ES2334149T3 (es) 2010-03-05
AU2005209256A1 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
HK1099228A1 (en) Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
PH12020551244A1 (en) Pd-1/pd-l1 inhibitors
IL169881A0 (en) Adhesive patches for the transdermal delivery of granisetron
TW200745078A (en) Isoindole-imide compounds and compositions comprising and methods of using the same
MY157495A (en) 6-,7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same
TW200608973A (en) Rapamycin polymorph Ⅱ and uses thereof
MX2009003038A (es) Derivados de quinazolinona 5-sustituidos como agentes antitumorales.
IL176142A0 (en) Processes for preparing montelukast sodium
TW200603783A (en) Non-nucleoside reverse transcriptase inhibitors
TW200731974A (en) Transdermal system for verenicline
TW200731991A (en) Lipophilic di(anticancer drug) compounds, compositions and related methods
ZA200709481B (en) Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV
SG155939A1 (en) Phosphoindoles as hiv inhibitors
WO2007120333A3 (en) Tetracyclic kinase inhibitors
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
TW200638932A (en) CCI-779 polymorph and use thereof
PL1865931T3 (pl) Plaster przezskórny
PH12019502290A1 (en) Therapeutic agent for blood cancer
UA91988C2 (ru) Фармацевтическая композиция на основе антагонистов nk2 для применения в педиатрии
DK1635843T3 (da) Terapi, der omfatter dienogest for hormonerstatning og depression
UA88325C2 (en) Phosphoindoles as hiv inhibitors
TW200505468A (en) Agent for improving hepato-bililary dysfunction
TW200621740A (en) Compound for treating hepatitis B and composition thereof
UA89625C2 (ru) Фосфонаты, монофосфонамидаты, бисфосфонамидаты для лечения вирусных заболеваний
TR200805408U (tr) Kendi̇nden kapsüllü taşima kulbu

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140121